2.8. LC-MS analysis of sildenafil

EH Emilie Hitzerd
MB Michelle Broekhuizen
KC Katrina M. Mirabito Colafella
MG Marija Glisic
RV René de Vries
BK Birgit C.P. Koch
MR Michiel A. de Raaf
DM Daphne Merkus
SS Sam Schoenmakers
IR Irwin K.M. Reiss
AD A.H. Jan Danser
SS Sinno H.P. Simons
request Request a Protocol
ask Ask a question
Favorite

The concentration of sildenafil in placental perfusate was measured with a FDA validated liquid chromatography-mass spectrometry method (LC-MS), using Thermo TQS Vantage LC-MS/MS for the analysis. Column 2·1 × 100mm Waters Acquity CSH C18 1·7um. The mobile phase A consisted of 2 mM ammonium acetate in 0·1% formic acid in water. The mobile phase B consisted of 2 mM ammonium acetate in 0·1% formic acid in LC-MS methanol. Flow rate was 0·5 mL/min. The mobile phase composition changed linearly during analysis in a percentage mobile phase A (from 80% to 0) and B (from 2% to 100%). Total analysis time was four min. The injected volume was 10 μL. Internal standard was vardenafil. The method was validated according to FDA guidelines between 2 and 1000 μg/L for sildenafil and 2–500 μg/L for desmethylsildenafil [37].

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A